These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4953658)

  • 1. Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. II. The emergence of resistance and its retardation in the course of monotherapy and combinations of antituberculous drugs.
    Havel A; Trnka L; Kuska J
    Chemotherapia (Basel); 1964-1965; 9(3):168-75. PubMed ID: 4953658
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. I. The antimycobacterial efficacy made in vitro and in vivo.
    Trnka L; Kuska J; Havel A
    Chemotherapia (Basel); 1964-1965; 9(3):158-67. PubMed ID: 4953657
    [No Abstract]   [Full Text] [Related]  

  • 3. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli.
    McCune RM; Feldmann FM; McDermott W
    J Exp Med; 1966 Mar; 123(3):469-86. PubMed ID: 4957011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher activity of morphazinamide over pyrazinamide against intracellular.
    Teyssier L
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):386. PubMed ID: 11334260
    [No Abstract]   [Full Text] [Related]  

  • 5. [MORPHAZINAMIDE IN ANTUBERCULAR THERAPY].
    FOUQUET J; TEYSSIER L
    G Ital Chemioter; 1963; 10():164-70. PubMed ID: 14079399
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental trials and clinical observations on the use of intravenous morphazinamide in chronic pulmonary tuberculosis].
    Di Perna A; Berti R; Cinotti D
    Minerva Med; 1965 Sep; 56(71):2872-8. PubMed ID: 4954934
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of the action of drugs in the short-course chemotherapy].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An experimental model of chemotherapy on dormant tuberculous infection, with particular reference to rifampicin.
    Kondo E; Kanai K
    Jpn J Med Sci Biol; 1988 Apr; 41(2):37-47. PubMed ID: 3149354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of tuberculosis. The Mitchell lecture 1979.
    Mitchison DA
    J R Coll Physicians Lond; 1980 Apr; 14(2):91-5, 98-9. PubMed ID: 6767845
    [No Abstract]   [Full Text] [Related]  

  • 12. Reappraisal of the activity of morphazinamide against M. tuberculosis.
    Bravo TC; Ellard GA; Mitchison DA
    Tubercle; 1975 Sep; 56(3):211-7. PubMed ID: 814663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary drug resistance of Mycobacterium tuberculosis in patients with chronic destructive forms of pulmonary tuberculosis].
    Poliakova AN; Ianovskaia OM; Samuliak ID; Vasilik GV; Matviĭchuk VM
    Vrach Delo; 1977 Jan; (1):97-9. PubMed ID: 403681
    [No Abstract]   [Full Text] [Related]  

  • 14. Basic mechanisms of chemotherapy.
    Mitchison DA
    Chest; 1979 Dec; 76(6 Suppl):771-81. PubMed ID: 92392
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
    Uttley AH; Collins CH
    Tubercle; 1988 Sep; 69(3):193-5. PubMed ID: 3151140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of antituberculosis drugs in short-course chemotherapy.
    Mitchison DA
    Tubercle; 1985 Sep; 66(3):219-25. PubMed ID: 3931319
    [No Abstract]   [Full Text] [Related]  

  • 17. The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
    Jindani A; Aber VR; Edwards EA; Mitchison DA
    Am Rev Respir Dis; 1980 Jun; 121(6):939-49. PubMed ID: 6774638
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary drug resistance in adult pulmonary tuberculosis].
    Porven G; Rodriguez EJ; Piccolo R
    Medicina (B Aires); 1973; 3(6):708-15. PubMed ID: 4217868
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in drug resistance of mycobacterium tuberculosis.
    Hejny J
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.